An alkaloid-rich phytopharmaceutical prepared from Qing Dai against IL-17A-induced psoriasis

J Ethnopharmacol. 2024 Jan 10;318(Pt A):116924. doi: 10.1016/j.jep.2023.116924. Epub 2023 Jul 15.

Abstract

Ethnopharmacological relevance: Psoriasis is a chronic inflammatory disease due to immune dysregulation that cannot be cured. The skin conditions of psoriasis negatively impact patients' quality of life worldwide. Qing Dai (Indigo Naturalis), a traditional Chinese medicine (TCM) processed from Strobilanthes cusia is a clinical medicine used for psoriasis patient in Taiwan and the gene overexpression of interleukin (IL)-17A could be notably reduced in skin lesions after using Qing Dai ointment and its alkaloid ingredients.

Aim of the study: To develop a potential anti-psoriatic phytopharmaceutical, an alkaloid-rich fraction named INM-A was prepared from Qing Dai. The chemical profile and anti-psoriatic activity of INM-A were analyzed and evaluated to define its in vitro mechanism and in vivo efficacy for psoriasis therapy.

Materials and methods: Dowex® 50WX4 hydrogen form resin was used for column chromatography to prepare INM-A. To track alkaloids, INM-A was conducted with Dragendorff's, Mayer's, and Wagner's reagents. HPLC and UV-Vis spectrophotometer were applied to analyze the chemical profile and relative total alkaloid content in INM-A. A psoriatic mouse model induced by imiquimod (IMQ) was performed to verify in vivo efficacy of INM-A. IL-17A-dominated cellular oxygen consumption rate, oxidative stress, and cytokines in keratinocytes were measured to clarify in vitro mechanism of INM-A.

Results: An alkaloid-rich fraction, INM-A, consisted of seven active alkaloid compounds 1-7 was obtained from Qing Dai. INM-A improved the skin condition severities in IMQ-induced psoriatic mice and decreased IL-17A in not only psoriatic mice but also polarized Th17 cells. In addition, INM-A targeted IL-17A to inhibit inflammation and OXPHOS-driven oxidative stress in human keratinocytes.

Conclusion: Accordingly, INM-A manufactured from Qing Dai may be a promising lead phytopharmaceutical for further IL-17A-related inflammatory disease studies such as psoriasis.

Keywords: Alkaloid-rich phytopharmaceutical (INM-A); Anti-OXPHOS-driven oxidative stress; Anti-inflammation; IL-17A inhibition; Psoriasis; Qing Dai (Indigo Naturalis).

MeSH terms

  • Alkaloids* / adverse effects
  • Animals
  • Antineoplastic Agents* / therapeutic use
  • Disease Models, Animal
  • Humans
  • Imiquimod
  • Interleukin-17
  • Keratinocytes / pathology
  • Mice
  • Mice, Inbred BALB C
  • Psoriasis* / chemically induced
  • Psoriasis* / drug therapy
  • Quality of Life
  • Skin / pathology

Substances

  • Interleukin-17
  • Qingdai compound
  • Imiquimod
  • Antineoplastic Agents
  • Alkaloids